Michael Mussallem, chairman and CEO of Irvine, Calif.-based devicemaker Edwards Lifesciences, discusses the company's plans, how his firm demonstrates the value of its products to health systems and the prospects for repeal of the medical-device tax. He spoke with Modern Healthcare reporter Jaimy...
The CMS will continue ordering some drug and device manufacturers to collect evidence on how well their technologies work before giving its final approval on reimbursement.
Researchers and cost-control advocates are increasingly questioning drugs, devices and procedures that proved effective in clinical trials but don't achieve the same outcomes once widely deployed. Sometimes they perform worse than cheaper alternatives already on the market.
Those squat disinfecting robots that zap deadly pathogens seem to have more personality than expected.
There is an economic benefit for payers and patients when using tomosynthesis, a more advanced form of mammography, to screen women for breast cancer at a time when adoption of the new technology is growing, researchers conclude in a study.
A growing number of university engineering and medical schools are launching new collaboratives after recognizing both perspectives are required for success in developing new medical technologies.
A Food and Drug Administration proposal to regulate laboratory-developed tests could upend a clinical sector that provides thousands of tests to healthcare providers every day, raising costs and potentially limiting patient access, detractors say.
Health providers should not hesitate to treat flu patients with antivirals, CDC says, and other news
Providers should not hesitate to treat hospitalized patients suspected of having influenza with antiviral medications, given the severity of the current flu season, health officials said Friday.
The CMS has proposed covering screenings for millions of eligible Medicare beneficiaries, which is expected to create a lucrative market for hospitals and medical manufacturers. Some CT scanner manufacturers are already marketing consulting services and technology to hospitals.
Larry Anstine, CEO of University Hospital at Ohio State University Wexner Medical Center, will retire in March, and other news makers
Larry Anstine, CEO of University Hospital at Ohio State University Wexner Medical Center, will retire in March after more than 25 years with OSU in Columbus.
Rev. Dennis Holtschneider, 52, has been named board chairman for St. Louis-based Ascension, the nation's largest Catholic health system and the largest U.S. private not-for-profit health system.
Matthew O’Brien, 40, has been hired as a principal and senior research analyst on the medical technology equity research team at Piper Jaffray, the Minneapolis-based investment bank and asset management firm.